NPR, December 11, 2015. Medical advisers to the Food and Drug Administration say that prescription opioid drugs containing codeine should not be used to treat children or the majority of teens suffering from pain or a cough.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Politicians Want to Speed Up Drug Approvals. That Could Backfire
The Washington Post, November 24, 2015. Two new studies show faster drug approvals don’t help people with Alzheimer’s, cancer, depression, multiple sclerosis, and Parkinson’s.
Read More »The 21st Century Cures Act Could be a Harmful Step Backward
The Washington Post, November 19, 2015. Precision medicine is the next big thing in health care, and it’s also one of the few health goals that Congress and the White House agree on. But while we await treatments targeting the precise genetic makeups of individuals and diseases, medical researchers still are not paying enough attention to the most important kinds of differences among patients: those of sex, age and race.
Read More »Experts Weigh In on 21st Century Cures Act
Medscape, November 18, 2015. Experts answer questions about the 21st Century Cures Act. Dr. Zuckerman shares why she believes the Act will allow unsafe and ineffective drugs to market.
Read More »Senate Counterpart to 21st Century Cures Bill is Struggling
Politico, October 25, 2015. The Senate’s companion effort to the House-passed 21st Century Cures is struggling to navigate a dramatically different political reality than the one that helped rocket the medical innovation bill through the lower chamber over the summer.
Read More »